Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
BD Announces Results For 2011 First Fiscal Quarter
Date:2/7/2011
p>
$
153,7314.44.6(0.2) Discovery Labware39,02538,3051.9(0.1)2.0TOTAL
$
199,512
$
192,0363.93.60.3TOTAL INTERNATIONAL
$
1,013,403
$
1,015,401(0.2)(0.3)0.1BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITSThree Months Ended December 31, (continued)(Unaudited; Amounts in thousands)Total % Change 20102009 Reported FXNFX ImpactBD MEDICAL Medical Surgical Systems
$
512,728
$
533,177(3.8)(4.7)0.9 Diabetes Care213,882201,5216.16.1- Pharmaceutical Systems199,937235,974(15.3)(12.4)(2.9)TOTAL
$
926,547
$
970,672(4.5)(4.3)(0.2)BD DIAGNOSTICS Preanalytical Systems
$
312,628
$
300,1664.23.90.3 Diagnostic Systems289,094295,308(2.1)(2.6)0.5TOTAL
$
601,722
$
595,4741.00.60.4BD BIOSCIENCES Cell Analysis
$
240,742
$
231,3354.14.2(0.1) Discovery Labware72,99471,3372.31.21.1TOTAL
$
313,736
$
302,6723.73.50.2TOTAL REVENUES
$
1,842,005
$
1,868,818(1.4)(1.5)0.1BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONSAFETY REVENUES(Unaudited; Amounts in thousands)Three Months Ended December 31, % Change 20102009 Reported FXNFX ImpactTOTAL SAFETY REVENUES United States
$
283,782
$
291,815(2.8)(2.8)- International169,254155,1299.17.51.6TOTAL
$
453,036
$
446,9441.40.90.5BY SEGMENT BD Medical
$
213,309
$
221,174(3.6)(4.3)0.7 BD Diagnostics239,727225,7706.25.80.4TOTAL
$
453,036
$
446,9441.40.90.5BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITS FISCAL 2010Revised for discontinued operations of certain Medical segment divestitures(Unaudited; A
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
2. BD Announces Agreement to Acquire Accuri Cytometers, Inc.
3. Misonix Announces Completion of Product Registrations in Key Latin American Markets
4. ConvaTec Announces New Appointments to Leadership Team
5. Medivation Announces Participation in 13th Annual BIO CEO & Investor Conference
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
9. Dendreon Announces Exercise and Closing of Overallotment Option
10. Hospira Announces FDA Approval of Topotecan Injection
11. BioNeutral Group Announces the Formation of Kentucky-Based BioNeutral Services, Inc. and the Appointment of Frank Battafarano as Chairman and CEO of BioNeutral Services, Inc.
Post Your Comments:
(Date:5/23/2013)... Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... ATLANTA , May 23, 2013 Inhibikase ... treatments, announced today that it will present new ... at an industry conference sponsored by the PML ... Biogen Idec). JC polyomavirus (JCV) is the causative ... host-directed tyrosine kinase inhibitor in an extended release ...
(Date:5/23/2013)... , May 23, 2013 ... MKT: NSPR), the leader in embolic protection stents, ... (MGuard for Acute ST Elevation Reperfusion) trial demonstrating ... bare metal and drug eluting stents in all-cause ... patients. Results from the trial were presented at ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5[0] Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease[0] Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)[0] InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
... Bayer HealthCare,Pharmaceuticals announced today the results of ... this week,at the American Academy of Neurology's ... tolerability, and high,patient satisfaction with treatment in ... , "Collectively, these studies highlight the important ...
... Study to be Part of Data Package Required ... /PRNewswire-FirstCall/ -- Novavax,Inc. said today that it has ... to ferrets inoculated with its pandemic,influenza vaccine, paving ... later this year. , In the study, ferrets ...
Cached Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 2Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 3(Date:5/23/2013)... San Francisco, CA (PRWEB) May 23, 2013 ... community safety outreach program being tackled by the Safe ... its second Fullpower personal safety workshop for ... develops and teaches personal safety skills programs for people ... been telling us their experiences with street harassment for ...
(Date:5/23/2013)... Lake City, Utah (PRWEB) May 23, 2013 ... Chevreau, PhD, R.D., published an article today on Tatalou.com ... an illness-free vacation. , The article, titled “ How ... why it’s important to carry hand sanitizer, when it’s ... to watch out for seafood, the importance of staying ...
(Date:5/23/2013)... 23, 2013 Dimensional Insight, a ... announced today that Paul Comras, director of ... at the 2013 International Medical Users Software Exchange ... & Revenue Visibility from Your General Ledger.” The ... from 2:30-3:25 p.m. in Azalea 1 at the ...
(Date:5/23/2013)... Alexandria, VA (PRWEB) May 23, 2013 Memorial ... start of the summer season for many Americans. Across the ... the long weekend. NHPCO encourages Americans to reach out to ... in military service. , As the nation marks Memorial Day ... Serious injuries and the untimely deaths of brave service men ...
(Date:5/23/2013)... To better serve the architecture ... pleased to announce the release of its new ... space division products. Provided by Koroseal, a leader ... patterns and colors represent a sophisticated response to ... a team of Koroseal experts, Modernfold reviewed hundreds ...
Breaking Medicine News(10 mins):Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 3Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 4Health News:How to Stay Healthy While Traveling 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:Memorial Day: Make it a Time of Remembrance and Support 2Health News:Memorial Day: Make it a Time of Remembrance and Support 3Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2[0] San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources[0] How to Stay Healthy While Traveling[0] Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference[0] Memorial Day: Make it a Time of Remembrance and Support[0] Modernfold Debuts New Colors and Patterns for Space Division Products
... treatment if they donate eggs for controversial cloning research.// ... for ‘egg sharing' so as to advance work on human ... this scheme and pass on their spare eggs to the ... by almost half. , ,The researcher team from ...
... of Agriculture have indicated the enhanced nutritive benefits of ... ,According to scientists, watermelons are a production ... the parent plant, which slows down once the melon ... 70 degrees, contained almost 40% of lycopene and 50 ...
... than with most modern antibiotics, according to a recent ... from the University of Bonn, Germany in collaboration with ... that medihoney is a very effective treatment for several ... infected with multi-resistant bacteria within a few weeks. ...
... and Channel 7 Indian Television network has raised many questions ... professionals. A cleaning up operation is long overdue to rejuvenate ... World Medical Association in 1949 - I ... of humanity …. I will practice my profession with conscience ...
... to an article that was published in the July 24 ... the JAMA/Archives journals, states that women who take// combination of ... have an increased risk of breast cancer. ... their normal levels of the testosterone hormone would be likely ...
... drug that is widely used in heart failure. Some ... is contraindicated. //However a new analysis shows that the ... heart failure. ,"Contrary to conventional wisdom, digitalis ... advances our understanding of both digitalis, the oldest known ...
Cached Medicine News:Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 3Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 2Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 3Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 4Health News:Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy 2Health News:Digitalis Could Be Safe In Diastolic Heart Failure 2Health News:Digitalis Could Be Safe In Diastolic Heart Failure 3IVF Price To Be Reduced If Women Opt For Egg Sharing SchemeWarm Watermelon Scores Over Cold In Nutritive ValueHoney Works Faster than Antibiotics in Healing WoundsMaimed Conscience and Maimed Beggars (Medical Ethics in India) – Part Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone TherapyDigitalis Could Be Safe In Diastolic Heart Failure
Very compressive support for submental liposuction...
Applies pressure on scalp to stretch it before surgery...
Deluxe Abdominal Binders...
Ideal for abdominal, flank, hip and thigh procedures....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |